𝔖 Bobbio Scriptorium
✦   LIBER   ✦

402 Dual Inhibition of the MEK and the PI3K-Akt-mTOR Pathways Using GSK1120212 (or UO126) and Everolimus Overcomes Resistance to MEK Inhibitors Used as Single Agents in Pancreatic Cancer Cells

✍ Scribed by Neuzillet, C.; Serova, M.; Raballand, A.; Astorgues-Xerri, L.; Riveiro, M.E.; de Gramont, A.; Ruszniewski, P.; Hammel, P.; Faivre, S.; Raymond, E.


Book ID
122840807
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
59 KB
Volume
48
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.